<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="http://pharmaexecnews.com/wp-content/plugins/google-sitemap-generator/sitemap.xsl"?><!-- generator="wordpress/2.8.4" --><!-- sitemap-generator-url="http://www.arnebrachhold.de" sitemap-generator-version="3.1.0.1" --><!-- generated-on="April 29, 2011 2:04 pm" --><!-- Debug: Total comment count: 0 --><urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">	<url>
		<loc>http://pharmaexecnews.com/</loc>
		<changefreq>daily</changefreq>
		<priority>1.0</priority>
	</url>
<!-- Debug: Start Postings --><!-- Debug: Priority report of postID 11539: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//preventing-colon-cancer-canola-oil/</loc>
		<lastmod>2011-04-27T15:16:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11535: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//breast-implants-lead-cancer/</loc>
		<lastmod>2011-04-27T15:09:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11531: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//brain-cell-protein-identified-potential-target-obesity-type-2-diabetes/</loc>
		<lastmod>2011-04-27T15:03:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11526: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//scientists-identify-gene-required-repairing-damaged-muscle/</loc>
		<lastmod>2011-04-27T14:58:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11522: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//antibiotics-cure-anthrax/</loc>
		<lastmod>2011-04-26T17:48:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11518: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//researchers-gain-insight-thalidomide-leads-birth-defects/</loc>
		<lastmod>2011-04-25T15:43:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11514: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//sunlight-exposure-common-virus-responsible-multiple-sclerosis/</loc>
		<lastmod>2011-04-25T15:36:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11510: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//preventing-damage-heart-attacks-strokes-injection/</loc>
		<lastmod>2011-04-25T15:22:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11506: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//researchers-develop-biosensor-microchip-boost-process-drug-development/</loc>
		<lastmod>2011-04-25T14:33:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11503: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//nanoparticles-kill-cancer-cells/</loc>
		<lastmod>2011-04-25T14:24:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11497: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//drug-shows-unprecedented-weight-loss-clinical-trials/</loc>
		<lastmod>2011-04-18T16:46:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11481: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//targeted-photodynamic-therapy-treating-skin-cancer/</loc>
		<lastmod>2011-04-18T16:46:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11493: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//coffee-addiction-linked-genetics/</loc>
		<lastmod>2011-04-15T15:25:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11489: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//classification-coli-bacteria/</loc>
		<lastmod>2011-04-15T15:04:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11485: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//nasal-spray-vaccines-effective-flu/</loc>
		<lastmod>2011-04-15T14:14:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11477: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//generation-medicines-evolution-biomolecules/</loc>
		<lastmod>2011-04-15T14:01:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11473: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//turning-blood-cells-beating-heart-cells/</loc>
		<lastmod>2011-04-15T13:59:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11469: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//production-mercury-microorganisms-researched/</loc>
		<lastmod>2011-04-15T13:55:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11465: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//india-agrees-check-superbug/</loc>
		<lastmod>2011-04-15T13:53:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11462: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//diagnosing-genetic-mutations-technology/</loc>
		<lastmod>2011-04-15T13:50:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11461: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//lack-leptin-lead-infertility-women/</loc>
		<lastmod>2011-04-08T03:09:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11459: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//alzheimer-disease-linked-herpes/</loc>
		<lastmod>2011-04-08T03:06:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11458: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//oxygen-natural-cure-cancer/</loc>
		<lastmod>2011-04-07T22:27:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11455: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//increased-inflammatory-responses-linked-p53-tumor-suppressor-gene/</loc>
		<lastmod>2011-04-07T22:24:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11452: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//merck-acquire-inspire-pharmaceuticals/</loc>
		<lastmod>2011-04-07T17:04:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11449: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//sudden-infant-death-syndrome-brain/</loc>
		<lastmod>2011-04-07T16:52:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11446: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//insulin-potential-cure-alzheimers/</loc>
		<lastmod>2011-04-07T14:55:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11442: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//breakthrough-battle-aids-protein-fragment-blocks-aids-virus-entry-cells/</loc>
		<lastmod>2011-04-07T14:51:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11439: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//detecting-cancer-carbon-nanotubes/</loc>
		<lastmod>2011-04-07T14:17:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11436: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//breast-tumors-unique-terms-genetics/</loc>
		<lastmod>2011-04-07T14:07:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11433: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//genetadi-biotech-identify-150-genetic-syndromes/</loc>
		<lastmod>2011-04-07T13:59:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11430: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//human-genetics-commission-approves-prepregnancy-genetic-disease-testing/</loc>
		<lastmod>2011-04-07T13:56:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11426: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//dealing-cancer-side-effects-nanopolymers/</loc>
		<lastmod>2011-04-07T13:52:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11422: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//boehringer-ingelheim-fda-thumbs-oncedaily-extendedrelease-viramune-tablet/</loc>
		<lastmod>2011-04-07T13:48:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11420: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//cells-gene-correction/</loc>
		<lastmod>2011-04-06T20:18:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11418: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//treating-wounds-bone-marrow-cells/</loc>
		<lastmod>2011-04-06T19:50:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11416: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//decreasing-prostate-cancer-risk-cardiac-drugs/</loc>
		<lastmod>2011-04-06T19:47:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11414: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//research-reveals-link-vitamin-stiff-arteries/</loc>
		<lastmod>2011-04-06T19:45:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11412: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//risk-epilepsy-influenced-potassium-channel-gene/</loc>
		<lastmod>2011-04-05T08:55:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11410: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//genes-identified-alzheimers-disease/</loc>
		<lastmod>2011-04-05T08:50:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11406: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//arthritis-drug-combat-melanoma-skin-cancer/</loc>
		<lastmod>2011-03-30T16:37:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11403: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//research-treating-fatal-blood-clots/</loc>
		<lastmod>2011-03-30T16:31:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11399: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//impact-parasitic-infection-behavior/</loc>
		<lastmod>2011-03-30T16:28:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11395: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//variations-taste-buds-linked-obesity-chronic-ear-inflammation/</loc>
		<lastmod>2011-03-30T16:24:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11391: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//researchers-identify-gene-responsible-severe-skin-condition-epilepsy-patients/</loc>
		<lastmod>2011-03-29T14:58:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11387: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//deriving-terrestrial-solutions-spacebound-bacteria/</loc>
		<lastmod>2011-03-29T14:39:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11383: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//radiation-fukushima-plant-high-insignificant/</loc>
		<lastmod>2011-03-23T14:06:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11355: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//switch-releases-insulin-discovered/</loc>
		<lastmod>2011-03-23T14:05:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11380: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//protein-suppressing-prostate-cancer-researchers-hope/</loc>
		<lastmod>2011-03-23T13:53:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11375: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//cells-identity/</loc>
		<lastmod>2011-03-23T13:49:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11372: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//method-developed-studying-gene-regulation/</loc>
		<lastmod>2011-03-23T13:46:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11369: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//novartis-completes-125m-acquisition-tianyuan/</loc>
		<lastmod>2011-03-23T13:41:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11365: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pancreatic-cancer-cured-malarial-drug/</loc>
		<lastmod>2011-03-21T18:19:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11361: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//glucose-testing-faster-smarter/</loc>
		<lastmod>2011-03-21T18:15:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11351: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//drug-target-structure-speed-drug-discovery/</loc>
		<lastmod>2011-03-21T18:11:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11347: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//visual-protein-folding-develop-brain-disease-therapies/</loc>
		<lastmod>2011-03-21T17:26:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11343: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//eye-circuitry-decoded-microscope/</loc>
		<lastmod>2011-03-21T16:16:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11330: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//berkshire-hathaway-picks-lubrizol/</loc>
		<lastmod>2011-03-18T15:37:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11338: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//fda-warns-drug-scams-play-radiation-fear/</loc>
		<lastmod>2011-03-18T15:36:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11334: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biotech-enzymes-protein-engineering/</loc>
		<lastmod>2011-03-18T14:16:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11327: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//breakdown-medicines-body-influenced-sunlight/</loc>
		<lastmod>2011-03-14T16:27:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11324: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//seat-fear-discovered-brain/</loc>
		<lastmod>2011-03-14T16:09:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11320: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//type-2-diabetes-role-brain-insulin/</loc>
		<lastmod>2011-03-14T15:47:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11316: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//act-receives-patent-generating-embryonic-stem-cells-embryo-destruction/</loc>
		<lastmod>2011-03-14T15:39:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11312: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//urethras-grown-laboratories/</loc>
		<lastmod>2011-03-09T17:18:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11307: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//brain-enzyme-erasesbrings-longterm-memories/</loc>
		<lastmod>2011-03-09T17:02:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11302: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//apple-day-doctor/</loc>
		<lastmod>2011-03-09T16:49:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11290: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//nanoparticles-long-lasting-immunity/</loc>
		<lastmod>2011-03-09T16:35:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11295: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//risk-loci-cardiovascular-disease-identified/</loc>
		<lastmod>2011-03-09T16:22:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11284: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//protection-asthma-bacteria-fungi/</loc>
		<lastmod>2011-03-09T14:58:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11279: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//link-discovered-schizophrenia-gene-mutation/</loc>
		<lastmod>2011-03-08T15:01:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11275: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//nanoparticles-mit-lead-vaccines-hiv-malaria/</loc>
		<lastmod>2011-03-08T14:47:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11264: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//research-proves-regrowth-newborn-heart/</loc>
		<lastmod>2011-03-08T14:33:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11268: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//transgenic-fungi-treat-malaria/</loc>
		<lastmod>2011-03-08T14:32:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11260: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//genetic-differences-cancer-noncancer-patients/</loc>
		<lastmod>2011-03-08T14:02:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11252: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//vertex-pharmaceuticals-move-cystic-fibrosis-drug/</loc>
		<lastmod>2011-03-08T13:50:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11251: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//hope-treating-sciatic-nerve-injury/</loc>
		<lastmod>2011-03-08T13:33:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11249: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//neglected-tropical-diseases-spotlight/</loc>
		<lastmod>2011-03-08T13:18:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11246: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//generic-fees-gain-traction-fda-backing/</loc>
		<lastmod>2011-02-23T01:20:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11243: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//medco-inline-profit-report-fails-excite-market/</loc>
		<lastmod>2011-02-23T01:09:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11240: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//senators-resurrect-reimportation-bill/</loc>
		<lastmod>2011-02-23T00:56:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11237: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//zymes-receives-michael-fox-foundation-grant-pd-therapy-research/</loc>
		<lastmod>2011-02-22T19:23:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11234: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//medtrust-avantra-partner-develop-biomarker-assays-cancer/</loc>
		<lastmod>2011-02-22T19:18:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11219: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//otc-allegra-nod-fortifies-sanofis-consumer-ops/</loc>
		<lastmod>2011-02-22T18:48:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11228: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//potential-drug-targets-discovered-preventing-prostate-cancer-cell-growth/</loc>
		<lastmod>2011-02-22T18:47:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11224: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pharmaceutical-industry-india-top-pharma-companies-jobs/</loc>
		<lastmod>2011-02-22T18:42:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11208: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//catalent-adds-fastdissolve-tech-oral-dose-arsenal/</loc>
		<lastmod>2011-02-22T14:45:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11214: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//fast-company-highlights-10-top-innovators-biotech/</loc>
		<lastmod>2011-02-22T14:39:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11211: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//printers-produce-human-skin/</loc>
		<lastmod>2011-02-22T14:34:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11205: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pneumococcal-vaccine-developed/</loc>
		<lastmod>2011-02-22T14:27:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11201: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//top-10-medical-device-venture-capital-deals-2010/</loc>
		<lastmod>2011-02-22T14:23:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11197: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//inhalable-measles-vaccine-tested/</loc>
		<lastmod>2011-02-16T14:26:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11193: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//naturally-occurring-brain-signaling-chemical-understanding-parkinsons/</loc>
		<lastmod>2011-02-16T14:22:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11189: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//delivering-potent-cancer-drug-nanoparticles-lessen-side-effects/</loc>
		<lastmod>2011-02-16T14:17:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11185: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//small-details-in-vivo-in-vitro-studies-big-differences/</loc>
		<lastmod>2011-02-16T14:11:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11182: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//mental-retardation-gene-insights-brain-formation/</loc>
		<lastmod>2011-02-16T14:06:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11177: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//chimerix-funds-antiviral-drug-work-45m/</loc>
		<lastmod>2011-02-14T22:05:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11173: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//rate-drug-approvals-dropping/</loc>
		<lastmod>2011-02-14T21:50:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11168: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//obamas-budget-delays-deep-cuts-physician-payments/</loc>
		<lastmod>2011-02-14T21:12:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11164: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//diabetes-researcher-close-cure/</loc>
		<lastmod>2011-02-13T23:43:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11160: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//specialty-drugmakers-big-pharma-buy/</loc>
		<lastmod>2011-02-13T23:39:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11156: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//stimulating-brains-immune-response-provide-treatment-alzheimers-disease/</loc>
		<lastmod>2011-02-09T17:59:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11150: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//cros-iphone-app-ondemand-study-updates/</loc>
		<lastmod>2011-02-08T17:20:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11146: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//court-clears-generic-allegra-sale/</loc>
		<lastmod>2011-02-08T17:09:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11142: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//nps-soars-positive-ph3-data-orphan-sbs-drug/</loc>
		<lastmod>2011-02-06T22:08:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11139: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//gene-relocation-key-evolutionary-change-bacteria/</loc>
		<lastmod>2011-02-06T20:34:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11135: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//adult-skin-cells-converted-beating-heart-cells/</loc>
		<lastmod>2011-02-02T19:14:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11131: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//obama-refight-battle-healthcare-law/</loc>
		<lastmod>2011-02-02T19:01:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11128: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//nanopopcorn-targets-cooks-tracks-prostate-cancer-cells/</loc>
		<lastmod>2011-02-01T16:55:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11124: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//copying-biotech-medicine-attracts-drugmakers/</loc>
		<lastmod>2011-01-25T15:12:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11120: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//domain-178m-deal-develop-parkinsons-drugs/</loc>
		<lastmod>2011-01-25T15:06:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11116: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//jj-teams-sanfordburnham-alzheimers-pact/</loc>
		<lastmod>2011-01-25T15:02:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11111: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//nasal-delivery-antivomiting-drug-patent-won/</loc>
		<lastmod>2011-01-25T14:57:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11107: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//ariad-shares-soar-cancer-drug-clears-latestage-trial/</loc>
		<lastmod>2011-01-25T14:53:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11103: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//hot-gold-nanoparticles-cook-cancer-cells/</loc>
		<lastmod>2011-01-19T17:17:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11099: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//researchers-unzip-mrsas-armor-vaccine/</loc>
		<lastmod>2011-01-19T16:54:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11094: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//plan-attack-breast-cancer-stem-cells/</loc>
		<lastmod>2011-01-19T16:45:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11090: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//inhaled-insulin-closer-reality/</loc>
		<lastmod>2011-01-19T16:32:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11085: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//gsk-malaria-vax-shows-promising-results/</loc>
		<lastmod>2011-01-18T15:45:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11082: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//big-biotech-joins-big-pharma-hunt-biosimilars/</loc>
		<lastmod>2011-01-17T22:18:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11078: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pfizer-bungles-taxfueled-champix-surge/</loc>
		<lastmod>2011-01-07T17:29:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11074: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//footstar-acquire-cpexs-drugdelivery-technology/</loc>
		<lastmod>2011-01-07T17:17:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11068: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//alfred-mann-doubles-biotech/</loc>
		<lastmod>2011-01-07T17:08:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11065: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pneumrx-lands-33m-lung-device/</loc>
		<lastmod>2011-01-07T16:45:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11061: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//bladder-regeneration-stem-cells-patients-bone-marrow/</loc>
		<lastmod>2011-01-07T16:32:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11057: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//burrill-predicts-big-surge-biotech-buyouts-2011/</loc>
		<lastmod>2011-01-03T20:26:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11053: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//copay-boosts-drugs-scares-payers/</loc>
		<lastmod>2011-01-03T20:09:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11048: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//scientists-peer-future-stem-cell-biology/</loc>
		<lastmod>2011-01-03T19:57:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11043: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//alzheimers-therapy-brain-disease-target-blood/</loc>
		<lastmod>2011-01-03T19:40:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11038: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//bacteria-provide-natures-immune-systems/</loc>
		<lastmod>2011-01-03T19:00:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11032: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//human-fetal-immune-system-arises-source-adult-immune-system/</loc>
		<lastmod>2010-12-27T16:40:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11027: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//alzheimers-tau-disrupts-neural-communication-prior-neurodegeneration/</loc>
		<lastmod>2010-12-27T15:37:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11018: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//goldplated-liposomes-anticancer-stocking-stuffer/</loc>
		<lastmod>2010-12-27T15:36:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11022: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//novartis-files-bexsero-approval/</loc>
		<lastmod>2010-12-27T15:12:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11014: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//worlds-stem-cell-trial-strokes/</loc>
		<lastmod>2010-12-27T14:30:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11008: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//big-pharma-big-emerging-markets/</loc>
		<lastmod>2010-12-27T14:18:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10996: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//college-students-mental-health/</loc>
		<lastmod>2010-12-21T16:43:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11003: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//hiv-cure-big-catch/</loc>
		<lastmod>2010-12-21T16:43:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10999: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//drug-helps-clear-lung-mucus-cystic-fibrosis-patients/</loc>
		<lastmod>2010-12-21T16:21:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10991: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//doctorpatient-relationship-compromised-facebook/</loc>
		<lastmod>2010-12-20T22:36:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10986: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//unraveling-alzheimers-simple-small-molecules-untangle-complex-disease/</loc>
		<lastmod>2010-12-11T00:19:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10982: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biotech-startup-tackles-cancer-stem-cells/</loc>
		<lastmod>2010-12-11T00:10:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10978: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//jj-recalls-rolaids-woodparticle-contamination/</loc>
		<lastmod>2010-12-11T00:06:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10974: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//fda-loses-battle-war-ecigarettes/</loc>
		<lastmod>2010-12-11T00:02:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10970: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//dry-powder-inhaler-stays-strong-breath-weak/</loc>
		<lastmod>2010-12-10T23:57:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10966: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//h1n1-vaccine-linked-700-increase-miscarriages/</loc>
		<lastmod>2010-12-10T23:53:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10962: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//experts-urge-start-stockpiling-cholera-vaccine/</loc>
		<lastmod>2010-12-07T01:30:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10958: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//star-trek-medical-technologies-today/</loc>
		<lastmod>2010-12-07T01:17:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10954: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//iphone-ipad-uk-health-system/</loc>
		<lastmod>2010-12-07T00:47:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10949: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//docs-police-social-media/</loc>
		<lastmod>2010-12-07T00:43:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10944: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//top-10-phase-iii-failures-2010/</loc>
		<lastmod>2010-11-29T18:16:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10940: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biotechs-biggest-spenders-2010/</loc>
		<lastmod>2010-11-29T18:10:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10936: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//expert-panel-recommends-gardasil-anal-cancer/</loc>
		<lastmod>2010-11-29T18:06:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10931: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//lh-merit-plan-medical-device-hirings/</loc>
		<lastmod>2010-11-29T18:02:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10927: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//fdas-top-q4-blockbuster-drug-decisions/</loc>
		<lastmod>2010-11-29T17:45:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10923: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//nanotechnology-promises-big-benefits-cancer-patients/</loc>
		<lastmod>2010-11-19T15:06:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10918: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//color-shape-pills-affects-patients-feel-medication/</loc>
		<lastmod>2010-11-19T15:00:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10914: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//backstabbing-bacteria-treatment-infection/</loc>
		<lastmod>2010-11-19T14:54:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10910: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//handheld-medical-devices-show-promise-radiology/</loc>
		<lastmod>2010-11-19T14:48:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10906: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//modulating-protein-control-alzheimers-disease/</loc>
		<lastmod>2010-11-19T14:44:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10902: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//researchers-discover-pain-gene-common-flies-mice-humans/</loc>
		<lastmod>2010-11-16T16:04:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10897: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//small-assist-device-emergency-case-twin-heart-booster-pumps/</loc>
		<lastmod>2010-11-16T16:00:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10893: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//embryonic-stem-cell-culturing-art-science/</loc>
		<lastmod>2010-11-16T15:36:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10889: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//benlysta-review-spooks-investors/</loc>
		<lastmod>2010-11-16T01:44:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10884: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//higher-income-parents-forgoing-kids-vaccinations/</loc>
		<lastmod>2010-11-04T16:55:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10863: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//brain-wired-attention/</loc>
		<lastmod>2010-11-04T16:55:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10880: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//veterans-bipolar-disorder-increased-risk-suicide/</loc>
		<lastmod>2010-11-04T16:39:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10876: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//amgen-proposes-key-hurdles-biosimilar-regs/</loc>
		<lastmod>2010-11-04T16:33:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10872: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//retinal-implant-enables-blind-people/</loc>
		<lastmod>2010-11-04T16:28:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10868: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//lilly-plans-complex-china/</loc>
		<lastmod>2010-11-04T16:20:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10859: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//charity-funds-brain-cancer-vaccine-trial/</loc>
		<lastmod>2010-10-27T15:51:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10855: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//diabetes-double-triple-2050/</loc>
		<lastmod>2010-10-27T15:45:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10851: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//novartis-file-meningitis-vaccine-infants/</loc>
		<lastmod>2010-10-27T15:36:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10846: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//parkinsons-drug-development/</loc>
		<lastmod>2010-10-26T16:32:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10842: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//fertilization-molecule/</loc>
		<lastmod>2010-10-26T16:31:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10838: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//migraine-botox-worth-1b/</loc>
		<lastmod>2010-10-21T13:50:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10834: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biotechnology-continues-bring-significant-funding/</loc>
		<lastmod>2010-10-21T13:45:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10830: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//potent-hepatitis-drug/</loc>
		<lastmod>2010-10-21T13:41:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10826: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//sanofi-partners-harvard-biomedical/</loc>
		<lastmod>2010-10-21T13:36:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10822: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//diagnosing-autism-mri/</loc>
		<lastmod>2010-10-21T13:32:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10818: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//children-adhd-missing-segments-dna/</loc>
		<lastmod>2010-10-15T21:27:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10814: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//drug-wholesalers-enjoy-financial-boost-year/</loc>
		<lastmod>2010-10-15T21:22:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10809: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//molecule-increases-survival-stomach-cancer-patients/</loc>
		<lastmod>2010-10-15T21:17:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10799: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//stem-cells-repair-damaged-spinal-cord-tissue/</loc>
		<lastmod>2010-10-15T21:12:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10804: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//diagnostic-startup-receives-33m-partners/</loc>
		<lastmod>2010-10-15T21:10:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10795: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//2010-biotech-graveyard/</loc>
		<lastmod>2010-10-07T22:00:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10791: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pharma-protests-indian-licensing-proposal/</loc>
		<lastmod>2010-10-07T21:55:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10787: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//cloaking-device-boldly-delivers-toxins-tumor/</loc>
		<lastmod>2010-10-07T21:51:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10778: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//experts-urge-making-cigarettes-nonaddictive-research-priority/</loc>
		<lastmod>2010-10-07T21:47:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10781: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//china-fuel-bigger-pharma-growth-2011/</loc>
		<lastmod>2010-10-07T21:46:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10774: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//big-pharmas-finding-ways-cut-costs-speed-trials/</loc>
		<lastmod>2010-10-04T20:35:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10770: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//singapore-plans-1-billion-fund-research-focuses-economic-returns/</loc>
		<lastmod>2010-10-04T20:30:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10766: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pharmas-expected-tackle-biosimilar-antibodies/</loc>
		<lastmod>2010-10-04T20:24:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10762: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//adult-stem-cells-age/</loc>
		<lastmod>2010-10-04T20:19:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10758: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//adult-stem-cell-therapies-making-rapid-progress-human-studies/</loc>
		<lastmod>2010-10-03T18:05:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10754: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//gsk-theravance-report-promising-phii-data-advair-successor/</loc>
		<lastmod>2010-09-24T21:29:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10750: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//layoffs-return-abbotts-3000-job-cuts/</loc>
		<lastmod>2010-09-24T21:24:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10746: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//sanofi-target-genzyme-attractive-buyers-unit-sales/</loc>
		<lastmod>2010-09-24T21:21:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10742: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//takeda-hopes-boost-chinese-ops/</loc>
		<lastmod>2010-09-24T21:14:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10738: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//obama-steps-defense-healthcare-overhaul-law/</loc>
		<lastmod>2010-09-24T21:10:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10734: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//chinese-company-big-microneedles/</loc>
		<lastmod>2010-09-22T14:41:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10729: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//boehringers-spiriva-challenge-serevent/</loc>
		<lastmod>2010-09-22T14:37:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10725: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//hiv-virus-hides-brain-swedish-study-finds/</loc>
		<lastmod>2010-09-20T23:22:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10720: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//az-bms-tout-batch-phiii-diabetes-data-dapagliflozin/</loc>
		<lastmod>2010-09-20T23:19:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10715: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//frances-alive-cord-blood/</loc>
		<lastmod>2010-09-19T23:12:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10711: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//drugs-pass-fda-muster-month/</loc>
		<lastmod>2010-09-12T13:14:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10707: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//cockroach-brains-source-antibiotics/</loc>
		<lastmod>2010-09-12T13:08:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10703: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//air-force-bans-ecigarettes/</loc>
		<lastmod>2010-09-12T12:34:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10699: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//400-medicines-vaccines-development-fight-infectious-diseases/</loc>
		<lastmod>2010-09-12T12:16:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10695: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//court-lifts-ban-stem-cell-funding-appeal/</loc>
		<lastmod>2010-09-12T01:32:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10691: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//research-scientists-brace-layoffs-stimulus-cash-dries/</loc>
		<lastmod>2010-09-06T17:36:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10683: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//docs-receptive-reps-confabs/</loc>
		<lastmod>2010-09-06T17:32:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10685: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pump-created-microneedle-drugdelivery-patch/</loc>
		<lastmod>2010-09-06T17:31:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10678: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//genetic-link-common-migraine/</loc>
		<lastmod>2010-09-06T17:23:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10674: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//hospital-cuts-staff-hires-robots-save-costs/</loc>
		<lastmod>2010-09-01T00:58:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10669: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//er-text-messaging-service-marketing-ploy/</loc>
		<lastmod>2010-09-01T00:21:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10665: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//nanotox-research-implications-nano-drug-delivery/</loc>
		<lastmod>2010-08-31T23:50:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10659: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//feds-aim-fortify-biodefense-fixing-product-development-pipeline/</loc>
		<lastmod>2010-08-29T16:54:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10657: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//surgeons-twitter-doublehand-transplant/</loc>
		<lastmod>2010-08-29T16:54:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10652: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//web-users-twitter-facebook-911-backup/</loc>
		<lastmod>2010-08-19T18:50:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10638: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//drug-counterfeiting-200-billion-business/</loc>
		<lastmod>2010-08-19T18:50:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10648: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//researchers-21m-study-hiv/</loc>
		<lastmod>2010-08-19T18:45:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10644: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//drug-recalls-hit-alltime-high/</loc>
		<lastmod>2010-08-19T18:35:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10632: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//fda-bans-cancer-drug-facebook/</loc>
		<lastmod>2010-08-19T18:28:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10619: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//china-plans-bolster-biotech/</loc>
		<lastmod>2010-08-12T15:23:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10627: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//declares-h1n1-pandemic-alert/</loc>
		<lastmod>2010-08-12T13:59:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10623: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//top-10-generic-drug-companies-2010/</loc>
		<lastmod>2010-08-12T13:38:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10614: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biotech-ma-frenzy-shows-sign-slowing/</loc>
		<lastmod>2010-08-12T13:26:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10609: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//remote-monitoring-aid-patients-offshore-oil-rigs/</loc>
		<lastmod>2010-08-12T13:21:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10604: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//males-dominate-hospital-ed-visits-underage-drinkers/</loc>
		<lastmod>2010-08-11T15:34:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10586: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//alzheimers-eyesight-important-connection/</loc>
		<lastmod>2010-08-10T00:08:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10596: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//ipad-live-healthcare-hype/</loc>
		<lastmod>2010-08-10T00:07:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10591: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//photos-dying-patient-posted-facebook/</loc>
		<lastmod>2010-08-10T00:07:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10582: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//earlystage-deals-lot-sweeter-biotechs/</loc>
		<lastmod>2010-08-05T00:21:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10577: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//payers-provenge-scripts-hit-500/</loc>
		<lastmod>2010-08-05T00:06:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10573: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pfizer-eyes-ma-emerging-markets/</loc>
		<lastmod>2010-08-04T23:52:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10569: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//sanofi-genzyme-buyout-price/</loc>
		<lastmod>2010-08-04T01:36:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10563: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biomedical-devices-powered-miniature-energy-harvesting-technology/</loc>
		<lastmod>2010-07-23T16:24:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10559: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//merck-buys-vax-unit-bankrupt-hawaii-biotech/</loc>
		<lastmod>2010-07-23T16:22:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10555: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//gsk-settles-paxil-suits-reported-1b/</loc>
		<lastmod>2010-07-23T16:10:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10551: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//milestones-mitigate-risk-biotech-deals/</loc>
		<lastmod>2010-07-23T16:05:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10547: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//utah-doctor-sentenced-years-illegal-online-pharmacy/</loc>
		<lastmod>2010-07-23T15:59:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10540: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//fastest-growing-therapeutic-classes-sales/</loc>
		<lastmod>2010-07-23T15:52:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10536: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pipeline-soften-lilly-patent-losses/</loc>
		<lastmod>2010-07-23T15:43:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10532: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//specially-engineered-immune-cells-ward-aids/</loc>
		<lastmod>2010-07-11T14:26:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10528: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//nigeria-takes-fake-drugs-technology/</loc>
		<lastmod>2010-07-11T14:07:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10523: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//top-10-pharma-ceo-salaries-2009/</loc>
		<lastmod>2010-07-11T13:40:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10519: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//merck-kgaas-pancreatic-cancer-vaccine-ready-testing/</loc>
		<lastmod>2010-07-11T13:08:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10512: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//mental-health-growing-concern-gulf-spill/</loc>
		<lastmod>2010-07-11T12:38:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10496: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//roche-cedes-power-jobs-genentech/</loc>
		<lastmod>2010-07-11T12:37:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10507: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//spin-dna-delivery-enhanced-delivery-method-dna-payloads-cells/</loc>
		<lastmod>2010-07-11T12:37:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10492: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biggest-developers-play-biosimilar-game/</loc>
		<lastmod>2010-07-11T12:01:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10502: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//jj-recalls-tylenol-overthecounter-drugs/</loc>
		<lastmod>2010-07-11T11:23:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10488: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//contract-manufacturing-doubledigit-growth/</loc>
		<lastmod>2010-07-11T11:22:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10465: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//importance-human-genome-sequencing-debated-10-years/</loc>
		<lastmod>2010-06-29T00:34:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10461: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//md-governor-touts-booming-biotech-biz-jobs/</loc>
		<lastmod>2010-06-29T00:33:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10459: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//bioterror-lab-target-infectious-disease-therapies/</loc>
		<lastmod>2010-06-29T00:33:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10463: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pfizers-litany-pipeline-snafus-analysts-fret/</loc>
		<lastmod>2010-06-29T00:32:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10467: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//antiviral-stem-cell-squad-dispatched-fight-deadly-hiv/</loc>
		<lastmod>2010-06-29T00:32:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10471: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//scientists-grow-lungs-skeletons/</loc>
		<lastmod>2010-06-29T00:31:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10469: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//synthetic-drug-users-forty-million/</loc>
		<lastmod>2010-06-29T00:29:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10455: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//synthetic-flu-virus-opens-door-safer-vaccines/</loc>
		<lastmod>2010-06-28T20:18:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10451: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//fda-imposes-hurdle-cytori-breast-repair-device/</loc>
		<lastmod>2010-06-28T20:05:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10447: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//diabetes-goals-sanofi/</loc>
		<lastmod>2010-06-27T23:10:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10432: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//stem-cells-create-abnormal-heart-cells/</loc>
		<lastmod>2010-06-16T15:05:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10429: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//drinking-coffee-reduce-risk-diabetes/</loc>
		<lastmod>2010-06-16T15:04:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10434: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//frontal-cortex-dysfunction-contribute-compulsive-sexual-behavior/</loc>
		<lastmod>2010-06-16T15:03:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10437: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//reducing-toxicity-lithium/</loc>
		<lastmod>2010-06-16T15:03:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10424: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//rfid-system-checks-rx-compliance/</loc>
		<lastmod>2010-06-16T14:14:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10420: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//forget-needles-please-delivers-drugs-lasers/</loc>
		<lastmod>2010-06-15T15:21:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10416: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//genome-sequencing-30-harvard-spinoff-promise/</loc>
		<lastmod>2010-06-15T15:06:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10412: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//jj-medical-devices-diagnostics-segment-receives-significant-regulatory-approvals/</loc>
		<lastmod>2010-06-15T00:19:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10407: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pharma-trifecta-generics-markets-personalization/</loc>
		<lastmod>2010-06-14T23:59:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10402: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//otsuka-arm-sales-reps-1300-ipads/</loc>
		<lastmod>2010-06-10T21:50:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10381: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//tetraphase-hauls-45m-antibiotic-work/</loc>
		<lastmod>2010-06-02T15:53:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10378: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//china-offers-cheaper-educated-labor/</loc>
		<lastmod>2010-06-02T15:51:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10385: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//stem-cell-culturing-breakthrough/</loc>
		<lastmod>2010-06-02T15:50:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10383: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pathway-cheap-insulin/</loc>
		<lastmod>2010-06-02T15:47:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10388: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//breast-cancer-detection-mammograms-improved/</loc>
		<lastmod>2010-06-02T15:46:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10368: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//medical-device-deals-decade/</loc>
		<lastmod>2010-05-29T13:58:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10366: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//clinical-conductor-clinical-trial-management-system-enjoys-record-growth/</loc>
		<lastmod>2010-05-29T13:57:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10363: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//iphone-app-patients-launched-shire/</loc>
		<lastmod>2010-05-29T13:57:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10361: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//medtronic-invest-70-million-israeli-heart-firm/</loc>
		<lastmod>2010-05-29T13:56:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10321: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//ge-healthcare-invests-5m-cardiodx/</loc>
		<lastmod>2010-05-17T18:10:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10337: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//generic-drug-potential-treatment-deadly-brain-cancer/</loc>
		<lastmod>2010-05-17T18:09:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10335: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//muscle-stem-cell-movements-documented/</loc>
		<lastmod>2010-05-17T18:08:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10330: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//inhalable-measles-vax-holds-promise-diseases/</loc>
		<lastmod>2010-05-17T18:07:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10341: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//stem-cells-search-master-controller/</loc>
		<lastmod>2010-05-17T18:05:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10325: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//dna-backbone-nextgeneration-logic-chips/</loc>
		<lastmod>2010-05-17T18:03:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10332: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//big-pharma-biotech-reengineering/</loc>
		<lastmod>2010-05-17T18:02:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10297: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//nerve-stem-cells-age/</loc>
		<lastmod>2010-05-10T18:10:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10307: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//global-cro-industry-chinas-growing-appeal/</loc>
		<lastmod>2010-05-10T18:09:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10301: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//genes-identified-variation-human-eye-color/</loc>
		<lastmod>2010-05-10T18:08:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10303: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pain-humans-animals-expressed-facial-expressions/</loc>
		<lastmod>2010-05-10T18:07:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10305: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//stem-cell-study-ms-shows-early-promise/</loc>
		<lastmod>2010-05-10T18:06:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10299: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//h1n1-vaccine-cancellations-novartis/</loc>
		<lastmod>2010-05-10T18:06:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10293: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biotech-companies-qualify-1b-cash-grants/</loc>
		<lastmod>2010-05-10T17:35:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10283: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//jj-childrens-drug-recall-congressional-investigation/</loc>
		<lastmod>2010-05-07T11:12:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10286: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//endometriosis-strong-period-pain-excess-weight-childhood-increases-risk/</loc>
		<lastmod>2010-05-07T11:11:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10274: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//nanoscale-probe-insert-medication-cell-wall/</loc>
		<lastmod>2010-05-04T01:05:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10277: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//stem-cells-improve-blood-flow-discarded-veins/</loc>
		<lastmod>2010-05-04T01:04:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10270: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//vitamin-status-quality-life-seniors/</loc>
		<lastmod>2010-04-26T18:20:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10266: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//studying-altered-brain-cells-sheds-light-epilepsy/</loc>
		<lastmod>2010-04-26T18:15:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10262: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//making-blind-gene-therapy-restores-vision-mice/</loc>
		<lastmod>2010-04-26T17:23:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10248: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//studies-nutrients-gene-expression-lead-tailored-diets-disease-prevention/</loc>
		<lastmod>2010-04-26T17:15:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10257: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//electronic-medical-record-technology-aids-marathon-participants/</loc>
		<lastmod>2010-04-26T17:14:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10252: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//forecasting-rates-overweight/</loc>
		<lastmod>2010-04-26T17:05:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10244: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//exposure-nitrogen-dioxide-lowers-vitro-fertilization-success/</loc>
		<lastmod>2010-04-13T19:15:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10239: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//oral-vaccine-reduce-exacerbations-patients-copd/</loc>
		<lastmod>2010-04-13T19:09:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10235: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//roche-deals-2010/</loc>
		<lastmod>2010-04-13T19:04:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10231: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//scientists-find-key-gene-promotes-cancer-metastasis/</loc>
		<lastmod>2010-04-13T18:59:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10227: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//novartis-unveils-positive-data-oral-ms-drug-gilenia/</loc>
		<lastmod>2010-04-13T18:52:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10223: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//work-pressures-nicotine-dependence-study-finds/</loc>
		<lastmod>2010-04-13T18:46:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10210: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//medications-faster-harvesting-biomolecules-quickly-reliably/</loc>
		<lastmod>2010-04-11T16:32:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10208: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//source-recurrent-yeast-infections-autoimmune-syndrome-pinpointed/</loc>
		<lastmod>2010-04-11T16:32:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10206: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//magnetic-attraction-stem-cells-creates-potent-treatment-heart-attack/</loc>
		<lastmod>2010-04-11T16:31:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10212: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//social-influence-plays-role-surging-autism-diagnoses-study-finds/</loc>
		<lastmod>2010-04-11T16:30:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10201: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//dna-nanotechnology-magic-bullets-breakthrough-offers-promising-applications-medicine/</loc>
		<lastmod>2010-04-11T16:09:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10179: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//jaw-bone-grown-adult-stem-cells/</loc>
		<lastmod>2010-04-01T01:06:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10182: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//scientists-reverse-alzheimerslike-memory-loss-fruit-flies/</loc>
		<lastmod>2010-04-01T01:04:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10173: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//compulsive-eating-shares-addictive-biochemical-mechanism-cocaine-heroin-abuse-study-shows/</loc>
		<lastmod>2010-04-01T01:03:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10184: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//judge-invalidates-human-gene-patent/</loc>
		<lastmod>2010-04-01T01:03:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10187: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//jaw-bone-grown-adult-stem-cells-2/</loc>
		<lastmod>2010-04-01T01:02:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10168: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//federal-court-rejects-vaccinesautism-link/</loc>
		<lastmod>2010-03-21T16:57:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10165: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//jj-rattles-analysts-long-delay-alzheimers-program/</loc>
		<lastmod>2010-03-21T16:56:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10159: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//recommendation-heart-failure-treatment-formulated/</loc>
		<lastmod>2010-03-21T16:46:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10155: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//chemists-influence-stemcell-development-geometry/</loc>
		<lastmod>2010-03-21T16:41:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10151: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//brain-abnormalities-identified-result-prenatal-methamphetamine-exposure/</loc>
		<lastmod>2010-03-21T16:37:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10147: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//acne-drug-prevents-hiv-breakout/</loc>
		<lastmod>2010-03-21T16:31:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10142: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//microbe-detective-seeks-germs/</loc>
		<lastmod>2010-03-21T16:26:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10136: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//feeling-lonely-adds-rate-blood-pressure-increase-people-50-years-older/</loc>
		<lastmod>2010-03-21T16:20:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10129: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//stem-cells-model-infant-birth-defect/</loc>
		<lastmod>2010-03-21T16:12:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10125: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//unique-genes-surrounding-sequences/</loc>
		<lastmod>2010-03-21T16:07:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10119: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//big-patent-expirations-2010/</loc>
		<lastmod>2010-03-06T15:11:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10115: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//hiring-reps-song-experience/</loc>
		<lastmod>2010-03-06T14:44:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10111: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//strategy-produces-promising-advance-cancer-vaccines/</loc>
		<lastmod>2010-03-06T14:10:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10107: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//skin-cells-repair-hearts-horizon-biomedical-scientist-brings-stem-cell-research-university/</loc>
		<lastmod>2010-03-06T13:48:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10103: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//handheld-device-prevent-migraine/</loc>
		<lastmod>2010-03-06T13:19:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10098: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//grady-hospital-improves-surgical-dept-efficiency/</loc>
		<lastmod>2010-03-06T12:58:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10093: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//clinical-trial-participation-improved-outcomes-childhood-cancer-patients/</loc>
		<lastmod>2010-03-06T12:23:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10088: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//experts-discuss-challenges-promises-personalized-medicine/</loc>
		<lastmod>2010-03-03T01:33:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10083: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//researchers-ready-leptin-test-type-1-diabetes/</loc>
		<lastmod>2010-03-03T01:06:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10079: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//prize-offer-millions-stem-cell-breakthrough/</loc>
		<lastmod>2010-03-03T00:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10075: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//novartis-eyes-deals-generics-vaccines/</loc>
		<lastmod>2010-02-26T17:55:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10068: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//effective-prostate-cancer-treatment-discovery/</loc>
		<lastmod>2010-02-26T17:36:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10061: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//mathematics-good-nights-sleep/</loc>
		<lastmod>2010-02-26T17:11:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10056: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pinch-pain-scorpion-venom-alternative-morphine/</loc>
		<lastmod>2010-02-26T16:51:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10050: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//unpacking-condensins-function-embryonic-stem-cells/</loc>
		<lastmod>2010-02-25T14:55:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10035: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//evidence-benefits-high-blood-pressure-drugs-diabetic-eye-disease/</loc>
		<lastmod>2010-02-25T13:45:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10041: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//sound-melanoma-ultrasound-doctors-find-cancer-accurately/</loc>
		<lastmod>2010-02-25T13:44:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10027: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//genetic-link-misery-death-discovered-strategy-probes-genetic-haystack/</loc>
		<lastmod>2010-02-25T13:14:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10022: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//effectiveness-asthma-relief-inhalers-discovery-opens-avenues-treatment-poorly-controlled-asthma/</loc>
		<lastmod>2010-02-19T16:55:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10016: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//dangers-older-allergy-drugs-underestimated-overlooked/</loc>
		<lastmod>2010-02-19T16:46:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10010: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//physicists-kill-cancer-nanobubbles/</loc>
		<lastmod>2010-02-19T16:33:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10005: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biologists-image-birth-bloodforming-stem-cells-embryo/</loc>
		<lastmod>2010-02-17T20:06:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10000: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//scientists-map-regions-genome-related-diabetes/</loc>
		<lastmod>2010-02-17T18:51:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9998: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//free-2010-biotechnology-trends-executive-report/</loc>
		<lastmod>2010-02-04T01:43:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9993: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//stem-cells-show-repair-bone-injuries-rats/</loc>
		<lastmod>2010-02-03T01:29:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9989: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//insect-cells-alternative-swine-flu-vaccines/</loc>
		<lastmod>2010-02-03T01:22:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9985: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//relation-childrens-brain-cancer-stem-cells/</loc>
		<lastmod>2010-02-03T01:16:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9981: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//rifampicin-promotes-radical-tuberculosis-strain-china/</loc>
		<lastmod>2010-02-03T01:07:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9977: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//fda-vyotrin-cancer/</loc>
		<lastmod>2010-02-01T19:57:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9972: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//hot-cancer-drug-chinese-mushrooms/</loc>
		<lastmod>2010-02-01T19:49:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9967: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//researchers-find-weakness-h1n1-evasion-methods/</loc>
		<lastmod>2010-02-01T19:42:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9962: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//47-million-doses-flu-vaccine-recalled-astrazeneca/</loc>
		<lastmod>2010-02-01T19:34:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9957: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//nanotechnology-improves-laboratory-based-heart-cell-growth/</loc>
		<lastmod>2010-02-01T19:27:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9939: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//novartis-pays-120m-buyout-corthera/</loc>
		<lastmod>2010-01-26T18:23:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9946: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//shionogi-futile-future-obesity-drug/</loc>
		<lastmod>2010-01-26T18:22:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9929: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//cell-state-change-mechanisms/</loc>
		<lastmod>2010-01-26T16:43:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9926: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//dna-sequencing-faster-cheaper/</loc>
		<lastmod>2010-01-26T16:42:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9923: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//xray-imaging-bacterial-cells/</loc>
		<lastmod>2010-01-26T16:40:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9917: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//watch-vitamin/</loc>
		<lastmod>2010-01-18T20:15:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9911: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//scientists-discover-group-viruses/</loc>
		<lastmod>2010-01-18T16:44:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9906: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//risk-severity-h1n1-flu-discovered/</loc>
		<lastmod>2010-01-18T16:34:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9901: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//protein-prevents-death-cancer-cells/</loc>
		<lastmod>2010-01-18T16:24:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9895: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//researchers-opportunity-annotate-genomes-experimentally/</loc>
		<lastmod>2010-01-18T16:12:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9889: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//advanced-discovered-treating-chronic-infections/</loc>
		<lastmod>2010-01-18T16:02:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9882: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//research-dna-damage-response/</loc>
		<lastmod>2010-01-18T15:52:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9850: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//accessing-drugs-imaging-technique/</loc>
		<lastmod>2009-12-31T18:18:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9855: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//morning-espresso-increase-atherosclerosis/</loc>
		<lastmod>2009-12-31T18:15:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9857: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//ice-cream-researchers-ice-cream-tastier-healthier/</loc>
		<lastmod>2009-12-31T18:13:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9865: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//sheer-mechanical-force-immune-response-diseases/</loc>
		<lastmod>2009-12-31T18:12:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9861: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pfizer-undertakes-major-cutbacks/</loc>
		<lastmod>2009-12-31T18:11:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9820: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//genetic-revolution-takes-aim-pipeline/</loc>
		<lastmod>2009-12-31T18:10:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9824: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//medicines-snags-rights-pfizer-heart-drug/</loc>
		<lastmod>2009-12-25T16:49:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9822: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//astrazeneca-pay-505m-novexel/</loc>
		<lastmod>2009-12-25T16:47:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9807: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//major-hospitals-adopt-medeanalytics-pai-solution-improve-patient-experience/</loc>
		<lastmod>2009-12-25T16:46:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9821: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//congress-prepares-deliver-biotechnology/</loc>
		<lastmod>2009-12-25T16:43:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9818: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//dealmaking-reaches-fever-pitch-years/</loc>
		<lastmod>2009-12-25T16:40:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9819: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//big-pharma-upends-empires/</loc>
		<lastmod>2009-12-25T16:40:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9812: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//oklahomas-largest-health-insurer-redesigns-web-site/</loc>
		<lastmod>2009-12-25T16:39:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9815: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biotech-2009/</loc>
		<lastmod>2009-12-24T21:59:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9691: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//generic-drugs-market-trends/</loc>
		<lastmod>2009-12-19T13:19:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7691: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pharmaceutical-biotech-executives-news-analysis-pharmaexecnewscom/</loc>
		<lastmod>2009-11-24T14:30:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1660: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//schizophrenia-symptoms-caused-traffic-jam-brain/</loc>
		<lastmod>2009-11-24T13:27:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1675: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//fda-supports-cervarix-gardasil/</loc>
		<lastmod>2009-11-12T13:09:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6752: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pharmareportscom-issues-2010-biotechnology-trends-executive-report/</loc>
		<lastmod>2009-11-12T13:08:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3251: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//government-healthcare-proposals-barr-illegal-immigrants-benefits/</loc>
		<lastmod>2009-10-27T17:41:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1658: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//cancer-promoted-macrophages/</loc>
		<lastmod>2009-10-02T14:14:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1655: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//gene-map-hiv-virus-deciphered-2/</loc>
		<lastmod>2009-10-02T14:14:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1699: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//stabilitech-stabilizes-drug-temperatures-budget/</loc>
		<lastmod>2009-10-02T14:13:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1701: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//hospitals-cutting-expenses-technology-investments/</loc>
		<lastmod>2009-10-02T14:13:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1703: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//cancer-drug-aflibercept-trials-halted-regeneron-sanofiaventis/</loc>
		<lastmod>2009-10-02T14:13:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1705: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//theravance-astellas-pharma-win-fda-approval-telavancin/</loc>
		<lastmod>2009-10-02T14:12:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1707: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//arizona-telemedicine-program-receives-grant/</loc>
		<lastmod>2009-10-02T14:12:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1709: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//dell-releases-emr-system/</loc>
		<lastmod>2009-10-02T14:11:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1663: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//swine-flu-antivirals-falls/</loc>
		<lastmod>2009-10-01T16:41:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1666: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//skin-aging-related-immune-defect/</loc>
		<lastmod>2009-10-01T16:40:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1669: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//obama-urges-public-brush-panic-maneuvers-2/</loc>
		<lastmod>2009-10-01T16:39:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1671: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//advances-drug-toxicity-microlivers/</loc>
		<lastmod>2009-10-01T16:38:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1673: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//fda-dynavax-hep-vax-program/</loc>
		<lastmod>2009-10-01T16:37:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1677: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//merck-significant-advances-oral-ms-drug-race/</loc>
		<lastmod>2009-10-01T16:35:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1679: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//stem-cells-produce-skin/</loc>
		<lastmod>2009-10-01T16:34:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1686: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//prostate-cancer-risk-blacks-whites-increased-obesity/</loc>
		<lastmod>2009-10-01T16:33:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1684: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//sparc-protein-key-link-obesity-diabetes/</loc>
		<lastmod>2009-10-01T16:32:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1681: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//uterine-fibroid-embolization-ufe-safe-nonsurgical-option/</loc>
		<lastmod>2009-10-01T16:31:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 531: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//trends-biochip-market/</loc>
		<lastmod>2009-09-15T19:51:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1399: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//alzheimers-prevented-reversed-caffeine/</loc>
		<lastmod>2009-09-15T18:17:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1397: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//health-care-funding-junk-food-sodas-taxed/</loc>
		<lastmod>2009-09-15T18:15:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1395: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//health-care-unaffordable-undeclared-war/</loc>
		<lastmod>2009-09-15T18:14:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1391: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//hormone-research-implications-womens-health/</loc>
		<lastmod>2009-09-15T18:13:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1389: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//magnesium-benefits-fully-explored/</loc>
		<lastmod>2009-09-15T18:12:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1387: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//metabolic-syndrome-breast-cancer/</loc>
		<lastmod>2009-09-15T18:11:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1385: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//prostate-cancer-preventable-fish-oil-omega3s/</loc>
		<lastmod>2009-09-15T18:09:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1556: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//cells-responsible-spread-bladder-cancer-discovered/</loc>
		<lastmod>2009-09-15T18:08:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1552: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//flu-vaccination-preliminary-injunction-issued/</loc>
		<lastmod>2009-09-15T18:07:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1548: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//gene-therapy-trial-successful-boosting-protective-protein-hereditary-lung-disease-patients/</loc>
		<lastmod>2009-09-15T18:05:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1544: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//hiv-blocking-gel-women-prevent-aids/</loc>
		<lastmod>2009-09-15T18:04:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1540: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//lung-cancer-prevented-spreading-brain/</loc>
		<lastmod>2009-09-15T18:03:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1536: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//phthalates-plastics-pose-danger-unborn-babies/</loc>
		<lastmod>2009-09-15T18:02:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1530: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//prostate-cancer-testing-harmful-beneficial/</loc>
		<lastmod>2009-09-15T18:01:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1525: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//stem-cell-behavior-regulation-genetic-circuit-discovered/</loc>
		<lastmod>2009-09-15T17:59:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1513: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//caffeine-intake-headaches/</loc>
		<lastmod>2009-09-15T17:58:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1507: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pain-spread-prolonged-active-marijuana-ingredients/</loc>
		<lastmod>2009-09-15T17:57:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1502: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//obama-urges-public-brush-panic-maneuvers/</loc>
		<lastmod>2009-09-15T17:56:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1498: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//gene-map-hiv-virus-deciphered/</loc>
		<lastmod>2009-09-15T17:55:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1413: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//stress-responses-linked-genes/</loc>
		<lastmod>2009-09-15T17:53:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1403: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//indian-biotech-companies-hit-exclusivity-law/</loc>
		<lastmod>2009-09-15T17:52:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1417: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//schistosoma-parasites-debilitating-infections/</loc>
		<lastmod>2009-09-15T17:51:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1393: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//heart-cells-automatically-regenerated-1-annually/</loc>
		<lastmod>2009-09-15T17:49:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1383: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//swine-flu-vaccine-diseased-african-monkeys/</loc>
		<lastmod>2009-09-15T17:48:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 359: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//cytotoxic-drugs/</loc>
		<lastmod>2009-09-15T17:46:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 361: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biochip-technology/</loc>
		<lastmod>2009-09-15T17:45:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 523: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//treating-ovarian-cancer-tropism-modified-oncolytic-adenovirus/</loc>
		<lastmod>2009-09-15T17:44:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 529: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//treating-tumors-ingn-007-vrx007-ingn-009-vrx009/</loc>
		<lastmod>2009-09-15T17:42:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 576: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//nanobiotechnology/</loc>
		<lastmod>2009-09-15T17:41:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 541: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//understanding-concept-bioburden/</loc>
		<lastmod>2009-09-15T17:40:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 545: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//francisella-tularensis-bioweapon/</loc>
		<lastmod>2009-09-15T17:38:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 117: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//bioinformatics-analysis-market-developments/</loc>
		<lastmod>2009-09-15T17:37:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 550: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//proteomics/</loc>
		<lastmod>2009-09-15T17:36:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 381: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biochips-robotics-engineering/</loc>
		<lastmod>2009-09-15T17:35:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 347: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//accessory-signaling-molecules/</loc>
		<lastmod>2009-09-15T17:33:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 521: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//treating-high-grade-astrocytomas-g207-viral-vector/</loc>
		<lastmod>2009-09-15T17:31:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1379: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//vitamin-deficiency-instant-solution-healthcare-reform/</loc>
		<lastmod>2009-09-15T17:29:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 504: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//symptoms-lymphoma/</loc>
		<lastmod>2009-09-09T21:54:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1229: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//eu-crackdown-pharma-industry/</loc>
		<lastmod>2009-09-09T21:50:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1274: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//proponents-threaten-withdraw-biologics-bill-support/</loc>
		<lastmod>2009-09-09T21:49:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://pharmaexecnews.com/sitemap/</loc>
		<lastmod>2009-09-09T11:53:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://pharmaexecnews.com/research-reports/</loc>
		<lastmod>2009-09-09T11:51:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://pharmaexecnews.com/submit-an-article/</loc>
		<lastmod>2009-08-19T18:40:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
<!-- Debug: Priority report of postID 1401: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//white-house-assures-drug-makers-drug-cost-deal/</loc>
		<lastmod>2009-08-12T21:34:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1405: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//viral-pandemics-history-412-bc-today/</loc>
		<lastmod>2009-08-12T21:33:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1407: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//type-2-diabetes-prevent/</loc>
		<lastmod>2009-08-12T21:32:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1409: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//telaprevir-launch-approaches-vertex-profits/</loc>
		<lastmod>2009-08-12T21:31:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1411: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//swine-flu-mass-vaccination-program/</loc>
		<lastmod>2009-08-12T21:31:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1415: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//sex-chromosome-males-losing-genes-rapid-evolution/</loc>
		<lastmod>2009-08-12T21:29:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1419: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//prescription-drug-benefit-program-flops/</loc>
		<lastmod>2009-08-12T21:26:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 537: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//understanding-genomics/</loc>
		<lastmod>2009-08-06T15:34:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1370: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pharma-funding-scrutiny/</loc>
		<lastmod>2009-08-01T12:01:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1368: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biotech-stocks-booming/</loc>
		<lastmod>2009-08-01T12:01:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 533: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//understanding-bioinformatics/</loc>
		<lastmod>2009-07-30T11:38:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 535: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//understanding-cloning-technology/</loc>
		<lastmod>2009-07-30T11:37:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 511: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//myriad-marburg-virus/</loc>
		<lastmod>2009-07-30T11:37:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 543: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//nanobiotechnology-diagnostics-therapeutics-medical-devices/</loc>
		<lastmod>2009-07-28T19:00:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 547: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biotechnology/</loc>
		<lastmod>2009-07-28T18:54:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 515: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//transductional-transcriptional-targeting-adenoviruses/</loc>
		<lastmod>2009-07-28T18:53:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1300: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pharmaceutical-companies-free-swine-flu-immunization-lawsuits/</loc>
		<lastmod>2009-07-28T17:27:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 539: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//understanding-pharmacogenetics/</loc>
		<lastmod>2009-07-24T23:24:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 513: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//reality-antidepressants/</loc>
		<lastmod>2009-07-24T23:17:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1291: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biologics-give-rise-exclusivity-debate/</loc>
		<lastmod>2009-07-24T23:02:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1287: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//america-ready-obama-health-plan/</loc>
		<lastmod>2009-07-23T23:16:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 552: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//structural-genomics/</loc>
		<lastmod>2009-07-17T16:47:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1265: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biotech-enhanced-crops-omega3-fatty-acids/</loc>
		<lastmod>2009-07-17T16:30:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1219: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biotech-drugs-year-protection/</loc>
		<lastmod>2009-07-14T17:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1209: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//congress-reform-healthcare/</loc>
		<lastmod>2009-07-13T17:35:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1226: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biotech-drug-copies-held-senate-plan/</loc>
		<lastmod>2009-07-12T04:14:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1216: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//drugmakers-reduce-medication-costs-elderly/</loc>
		<lastmod>2009-07-12T04:12:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1171: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//uk-government-support-industrial-biotechnology-sector/</loc>
		<lastmod>2009-06-30T22:55:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1169: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pharmaceutical-industry-reduce-drug-costs/</loc>
		<lastmod>2009-06-30T22:54:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1133: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//nanoparticles-replace-chemotherapy/</loc>
		<lastmod>2009-06-30T22:49:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1141: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//wyeth-pharmaceuticals-loses-court-battle-tune-67-million/</loc>
		<lastmod>2009-06-30T22:48:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1137: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//seroquel-zyprexa-geodon-treat-children/</loc>
		<lastmod>2009-06-30T22:46:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1151: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//fda-regulates-tobacco-war-smoking/</loc>
		<lastmod>2009-06-30T22:44:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 518: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//treating-attention-deficit-disorder/</loc>
		<lastmod>2009-06-19T20:23:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1102: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//north-carolina-grants-finance-develop-nanobiotechnology/</loc>
		<lastmod>2009-06-19T20:22:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1075: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//vitamin-raise-brain-power/</loc>
		<lastmod>2009-06-19T20:19:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1073: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//climatebased-biotechnology-model-dengue-outbreaks/</loc>
		<lastmod>2009-06-19T20:15:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1077: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//competing-biosimilars-proposed-legislation/</loc>
		<lastmod>2009-06-19T20:14:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1067: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//australian-biotech-industry-receives-boost-budget/</loc>
		<lastmod>2009-06-19T20:12:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1071: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pharma-companies-receive-seed-strains-swine-flu-vaccine/</loc>
		<lastmod>2009-06-19T20:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1063: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//small-business-innovation-research-program-tool-biotech-stalled-congress/</loc>
		<lastmod>2009-06-17T22:20:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 352: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//bioarrays/</loc>
		<lastmod>2009-06-05T19:41:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1052: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//diversity-biotechnology-boost-virginia-state/</loc>
		<lastmod>2009-06-05T19:39:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1054: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//cdc-swine-flu-threat/</loc>
		<lastmod>2009-06-05T19:37:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 383: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//conventional-modern-approaches-constructing-biochip-systems/</loc>
		<lastmod>2009-06-04T16:34:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 385: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//determine-stage-lymphoma/</loc>
		<lastmod>2009-06-04T16:33:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 387: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//emergence-plasma-donation/</loc>
		<lastmod>2009-06-04T16:33:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 389: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//esensor-dna-diagnostics/</loc>
		<lastmod>2009-06-04T16:32:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 392: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//basic-information-prostate-cancer/</loc>
		<lastmod>2009-06-04T16:31:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 394: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//facts-hodgkins-lymphoma/</loc>
		<lastmod>2009-06-04T16:31:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 396: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//failure-treatment-lymphoma/</loc>
		<lastmod>2009-06-04T16:27:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 398: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//febit-holding-introduces-geniomrt-analyzer/</loc>
		<lastmod>2009-06-04T16:27:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 400: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//fluid-technology/</loc>
		<lastmod>2009-06-04T16:26:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 402: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//focus-electrophoresis/</loc>
		<lastmod>2009-06-04T16:25:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 404: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//future-market-perspectives-nanobiotechnology/</loc>
		<lastmod>2009-06-04T16:25:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 406: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//gene-expression-chip/</loc>
		<lastmod>2009-06-04T16:24:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 408: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//genomic-revolution/</loc>
		<lastmod>2009-06-04T16:23:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 410: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//groups-viral-vectors/</loc>
		<lastmod>2009-06-04T16:23:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 412: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//avoid-breast-cancer/</loc>
		<lastmod>2009-06-04T16:22:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 414: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//deal-depression/</loc>
		<lastmod>2009-06-04T16:22:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 416: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//hybridization/</loc>
		<lastmod>2009-06-04T16:21:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 418: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//implications-human-genome-project/</loc>
		<lastmod>2009-06-04T16:20:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 420: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//importance-bacteriophages/</loc>
		<lastmod>2009-06-04T16:19:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 422: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//importance-oncolytic-viruses/</loc>
		<lastmod>2009-06-04T16:19:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 424: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//impotency-prostate-cancer-patients/</loc>
		<lastmod>2009-06-04T16:18:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 144: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//chemotherapy-cytotoxic-drugs-cancer-treatment/</loc>
		<lastmod>2009-06-04T16:18:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 202: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//overturning-restrictive-stem-cell-policies-bring-significant-scientific-potential-human-embryonic-stem-cell-research/</loc>
		<lastmod>2009-06-04T16:16:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 426: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//laboratoryonabead-technology/</loc>
		<lastmod>2009-06-04T16:14:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 428: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//learning-breast-cancer/</loc>
		<lastmod>2009-06-04T16:13:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 430: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biopharmaceuticals/</loc>
		<lastmod>2009-06-04T16:12:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 432: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//cerebral-palsy/</loc>
		<lastmod>2009-06-04T16:12:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 434: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//inflammatory-diseases/</loc>
		<lastmod>2009-06-04T16:11:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 436: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//genome-adenovirus/</loc>
		<lastmod>2009-06-04T16:11:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 438: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//herpesvirus/</loc>
		<lastmod>2009-06-04T16:10:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 441: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//reovirus/</loc>
		<lastmod>2009-06-04T16:10:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 443: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//mapping-chinese-genome/</loc>
		<lastmod>2009-06-04T16:09:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 445: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//microarrays-diagnostics/</loc>
		<lastmod>2009-06-04T16:08:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 447: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//modern-insulin-delivery-devices/</loc>
		<lastmod>2009-06-04T16:08:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 449: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//myocardial-infarction/</loc>
		<lastmod>2009-06-04T16:07:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 451: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//offshoring-pharmaceutical-sector/</loc>
		<lastmod>2009-06-04T16:07:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 453: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//outsourcing-pharmaceutical-industry/</loc>
		<lastmod>2009-06-04T16:06:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 455: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//patents-intellectual-property-rights-biopharmaceutical-industry/</loc>
		<lastmod>2009-06-04T16:06:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 457: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pathology-epsteinbarr-virus/</loc>
		<lastmod>2009-06-04T16:05:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 460: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pegylation-chemistry-mechanisms/</loc>
		<lastmod>2009-06-04T16:05:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 462: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//plaque-rupture-thrombus-formation/</loc>
		<lastmod>2009-06-04T16:04:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 464: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//potential-health-effects-cytotoxic-drugs-waste/</loc>
		<lastmod>2009-06-04T16:03:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 466: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//potential-iceminus-bacteria/</loc>
		<lastmod>2009-06-04T16:01:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 468: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//prescription-drug-information/</loc>
		<lastmod>2009-06-04T16:00:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 470: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//processes-involved-proteomics/</loc>
		<lastmod>2009-06-04T16:00:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 473: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//prostate-cancer-diet/</loc>
		<lastmod>2009-06-04T15:59:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 475: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//protein-chip-technology/</loc>
		<lastmod>2009-06-04T15:59:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 478: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//protein-structure-initiative/</loc>
		<lastmod>2009-06-04T15:58:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 480: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pulmonary-malignant-granular-cell-tumour/</loc>
		<lastmod>2009-06-04T15:58:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 482: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//research-nanobiotechnology/</loc>
		<lastmod>2009-06-04T15:56:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 484: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//rise-indian-pharmaceutical-industry/</loc>
		<lastmod>2009-06-04T15:55:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 486: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//role-albumin/</loc>
		<lastmod>2009-06-04T15:54:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 488: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//role-genomics-drug-development/</loc>
		<lastmod>2009-06-04T15:53:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 490: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//role-proteomics-drug-discovery/</loc>
		<lastmod>2009-06-04T15:53:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 492: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//role-technology-drug-development/</loc>
		<lastmod>2009-06-04T15:52:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 494: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//safety-viral-g207-vector/</loc>
		<lastmod>2009-06-04T15:51:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 496: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//selecting-optimal-treatment/</loc>
		<lastmod>2009-06-04T15:50:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 498: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//strategic-alliances-drug-development/</loc>
		<lastmod>2009-06-04T15:49:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 500: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//studying-recombinant-vesicular-stomatitis-virus-rvsv/</loc>
		<lastmod>2009-06-04T15:48:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 502: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//finding-support-groups-prostate-cancer/</loc>
		<lastmod>2009-06-04T15:48:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 506: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//breast-cancer/</loc>
		<lastmod>2009-06-04T15:46:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 509: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//future-nanobiotechnology/</loc>
		<lastmod>2009-06-04T15:43:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 555: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//india-launch-biotech-units-states/</loc>
		<lastmod>2009-06-04T15:43:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 736: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biotechnology-industry-organization-demands-economic-stimulus/</loc>
		<lastmod>2009-06-04T15:42:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 48: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//prostate-cancer-treatment/</loc>
		<lastmod>2009-06-04T15:41:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 101: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biotechnology-capillary-electrophoresis/</loc>
		<lastmod>2009-06-04T15:38:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 769: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//medical-device-safety-act-2009/</loc>
		<lastmod>2009-06-03T15:10:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 893: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//spend-billion-dollars-swine-flu-vaccine/</loc>
		<lastmod>2009-06-03T15:10:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 668: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//buying-drugs-online-harmful-trend/</loc>
		<lastmod>2009-06-03T15:10:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 738: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//genentech-receives-blow-fda-warning-cancer-drug/</loc>
		<lastmod>2009-06-03T15:09:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 896: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//scientific-american-rates-competitive-countries-biotech-sector/</loc>
		<lastmod>2009-05-24T13:51:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 882: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//understanding-obamas-healthcare-reforms/</loc>
		<lastmod>2009-05-24T12:50:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 851: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//obama-revises-guidelines-federal-funding-embryonic-stem-cell-research/</loc>
		<lastmod>2009-05-24T12:48:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 787: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//york-city-attract-biotech-companies/</loc>
		<lastmod>2009-05-24T12:47:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 870: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//proposed-patent-reform-act-2009/</loc>
		<lastmod>2009-05-23T01:23:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 817: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//nhs-funding-problems-developing-stem-cells/</loc>
		<lastmod>2009-05-18T20:33:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 106: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//bioinformatics-drug-discovery-development/</loc>
		<lastmod>2009-05-18T20:15:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 791: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//cancer-patients-challenge-patenting-gene-ovarian-breast-cancer/</loc>
		<lastmod>2009-05-18T20:11:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 77: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//hemophilia-plasma-donation/</loc>
		<lastmod>2009-05-11T12:57:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 689: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//university-wisconsinmilwaukee-research-pharmaceuticals-water/</loc>
		<lastmod>2009-05-11T12:48:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 507: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//debates-improvement-affordable-medicinal-costs-highlights-risks-benefits-brand-exclusivity-patent-laws/</loc>
		<lastmod>2009-05-07T21:55:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 528: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//vaccines-provide-biotechnology-pharmaceutical-industry-unlimited-potential-market-generic-brand-companies-gaining-ground/</loc>
		<lastmod>2009-05-07T21:54:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 660: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biotech-startups-venture-capital/</loc>
		<lastmod>2009-05-07T21:54:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 89: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//breast-cancer-surgery/</loc>
		<lastmod>2009-05-05T21:20:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 613: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//agri-biotechnology-research-boost/</loc>
		<lastmod>2009-05-05T21:20:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 607: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//canadas-drug-safety-system-favors-pharmaceutical-companies/</loc>
		<lastmod>2009-05-05T21:20:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 114: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biotechnology-applications-biochip-technology/</loc>
		<lastmod>2009-05-05T21:20:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 601: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//teva-pharmaceuticals-begins-marketing-pfizers-generic-zoloft-brand/</loc>
		<lastmod>2009-05-05T21:20:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 684: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biotech-swine-flu/</loc>
		<lastmod>2009-05-05T21:20:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 599: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//warfarin-black-box-warning-weigh-drugs-risks-benefits/</loc>
		<lastmod>2009-05-05T21:20:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 129: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pcr-relationship-biochip-technology/</loc>
		<lastmod>2009-04-24T11:55:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 135: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//acidophilus/</loc>
		<lastmod>2009-04-15T17:35:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 561: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//g20-pharma-stimulus-package/</loc>
		<lastmod>2009-04-13T11:07:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 108: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pegylation-advantages-potential/</loc>
		<lastmod>2009-04-10T20:23:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 120: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//artificial-intelligence-biochips-robotics-engineering/</loc>
		<lastmod>2009-04-02T00:21:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 285: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//nanotechnology-important-biotechnology-field/</loc>
		<lastmod>2009-04-01T23:59:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 84: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//dna-structure-developments-constructing-biochip-systems/</loc>
		<lastmod>2009-04-01T20:41:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 98: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//cellular-adhesion-molecules-selectins/</loc>
		<lastmod>2009-03-17T16:02:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 280: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biotechnology-development-biochip-industry/</loc>
		<lastmod>2009-03-17T16:01:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 69: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//gene-therapy-cytolytic-viruses/</loc>
		<lastmod>2009-03-17T15:34:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 111: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//gene-therapy-adenovirusmediation/</loc>
		<lastmod>2009-03-17T15:30:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 132: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//dna-analysis-bioarrays/</loc>
		<lastmod>2009-03-16T18:04:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//barack-obama-and-stem-cell-research/</loc>
		<lastmod>2009-03-16T15:58:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 139: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//crp-creactive-protein-accessory-signaling-molecule/</loc>
		<lastmod>2009-03-16T14:08:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: End Postings --><!-- Debug: Start Custom Pages --><!-- Debug: End Custom Pages --><!-- Debug: Start additional URLs --><!-- Debug: End additional URLs --></urlset>
